<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80-pharmaceuticals-13-00096">
 <label>80.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Patera</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Drewry</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Beiter</surname>
    <given-names>E.R.</given-names>
   </name>
   <name>
    <surname>Osborne</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hotchkiss</surname>
    <given-names>R.S.</given-names>
   </name>
  </person-group>
  <article-title>Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1</article-title>
  <source>J. Leukoc. Biol.</source>
  <year>2016</year>
  <volume>100</volume>
  <fpage>1239</fpage>
  <lpage>1254</lpage>
  <pub-id pub-id-type="doi">10.1189/jlb.4HI0616-255R</pub-id>
  <pub-id pub-id-type="pmid">27671246</pub-id>
 </element-citation>
</ref>
